The ASCO Annual Meeting is being held June 2 to 6, and here is some of the notable research that will be presented today. Topics include treatment for anemia related to myelodysplastic syndromes, pembrolizumab for advanced cervical cancer, surgery options for early pancreatic cancer, weight loss in breast cancer survivorship, the effect of Medicare expansion on racial disparities, and collaborating across borders to help children with leukemia.

Read research from the January 2023 session of the ASCO Plenary Series, which highlights a study evaluating a blood-based test to select treatment for advanced gastrointestinal stromal tumors (GISTs).

In this podcast, Dr. Frank Penedo interviews esophageal cancer survivor Rachael Kearney about her experience being diagnosed with cancer, how she coped with side effects from treatment, and her advice for sharing your cancer story.

The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include targeted therapy for advanced hormone receptor-positive, HER2-negative breast cancer and using liquid biopsy to guide post-surgery treatment decisions for stage II colon cancer.

Read research from the February 2022 session of the ASCO Plenary Series, which highlights a study on daily aspirin to prevent breast cancer recurrence and another on using targeted therapy to treat advanced pancreatic cancer with a specific mutation.

Read research from the January 2022 session of the ASCO Plenary Series, which highlights a study comparing 2 targeted therapies in treating advanced gastrointestinal stromal tumors (GISTs).

Research from ASCO’s 2022 Gastrointestinal Cancers Symposium will feature 2 abstracts that looked at using immunotherapy to treat advanced liver cancer and biliary tract cancer.

At the 2020 Gastrointestinal Cancers Symposium, research highlights include disparities in care among young adults with colorectal cancer, patient-reported outcomes in liver cancer and colorectal cancer, and a blood-based test to find hard-to-detect cancers.

Survivor and advocate Florence Kurttila describes her key takeaways from the 2019 Gastrointestinal Cancers Symposium.